<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3626">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04579588</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-58356</org_study_id>
    <secondary_id>5U19AI057229-17</secondary_id>
    <nct_id>NCT04579588</nct_id>
  </id_info>
  <brief_title>Understanding Immunity to the Flu Vaccine in COVID-19 Patients</brief_title>
  <official_title>Understanding Immunity to the Flu Vaccine in COVID-19 Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to measure immunity to the flu vaccine over time in patients who&#xD;
      had COVID-19. Adults who have been diagnosed with COVID-19 as well as controls without&#xD;
      COVID-19 will be invited to participate in this study.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">October 29, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Testing immunity to the flu vaccine over time</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Corona Virus Infection</condition>
  <condition>Flu Vaccine</condition>
  <condition>Immunity</condition>
  <arm_group>
    <arm_group_label>COVID-19 participants</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Control participants</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Flu shot</intervention_name>
    <description>All participants will receive a single shot of the flu vaccine</description>
    <arm_group_label>COVID-19 participants</arm_group_label>
    <arm_group_label>Control participants</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adults (18 years and older) diagnosed and not diagnosed (controls) with COVID-19&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults enrolled in study 55689 (NCT04373148)&#xD;
&#xD;
          -  Adults diagnosed with severe or moderate COVID-19 at least 2 months prior enrollment&#xD;
&#xD;
          -  Adults without COVID-19 diagnosis for healthy controls&#xD;
&#xD;
          -  Healthy controls may also be recruited outside of IRB#55689&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Received the influenza vaccine less than 4 months ago&#xD;
&#xD;
          -  Pregnant or lactating&#xD;
&#xD;
          -  Patients with special risks attendant to venipuncture&#xD;
&#xD;
          -  Adults who test positive for COVID-19 (pcr test)&#xD;
&#xD;
          -  Use of immunomodulatory medications&#xD;
&#xD;
          -  Immunodeficiency or autoimmune disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kari Nadeau, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University, Hospital, and Clinics</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94035</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>October 6, 2020</study_first_submitted>
  <study_first_submitted_qc>October 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 8, 2020</study_first_posted>
  <last_update_submitted>January 15, 2021</last_update_submitted>
  <last_update_submitted_qc>January 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Kari Christine Nadeau, MD PhD</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

